Anxiety and Anxiolytic Drugs

  • Florian Holsboer
  • Andreas Ströhle

Part of the Handbook of Experimental Pharmacology book series (HEP, volume 169)

Table of contents

  1. Front Matter
    Pages I-XIII
  2. C.T. Wotjak
    Pages 1-34
  3. F. Ohl
    Pages 35-69
  4. A. Bilkei-Gorzo, A. Zimmer
    Pages 143-162
  5. K. R. Merikangas, N. C. P. Low
    Pages 163-179
  6. A. Neumeister, R.J. Daher, D.S. Charney
    Pages 205-223
  7. H. Möhler, J.-M. Fritschy, K. Vogt, F. Crestani, U. Rudolph
    Pages 225-247
  8. W. Zieglgänsberger, C.G. Parsons, W. Danysz
    Pages 249-303
  9. R. Landgraf
    Pages 335-369
  10. R. Yehuda
    Pages 371-403
  11. M.T. Lin, K.-M. Lin
    Pages 433-447
  12. M.E. Keck, A. Ströhle
    Pages 449-468
  13. J.R. Nash, D.J. Nutt
    Pages 469-501
  14. E.B. Binder, F. Holsboer
    Pages 527-546
  15. C.W. Turck
    Pages 547-560
  16. Back Matter
    Pages 561-566

About this book


The present volume gives a comprehensive overview on the current state of basic and clinical research on Anxiety and Anxiolytic Drugs. Using newly developed methods and techniques researchers are now beginning to understand the molecular mechanisms of anxiety, anxiety disorders and their treatment. In parallel, new drug targets have been generated and the first clinical studies with new compounds have been started. In 20 chapters written by numerous experts in the field comprehensive information on all relevant topics is provided.


Anxiety Anxiolytic Drugs Neuropsychopharmacology Neuroscience Pharmacology neuropeptides pathophysiology physiology

Editors and affiliations

  • Florian Holsboer
    • 1
  • Andreas Ströhle
    • 2
  1. 1.Max-Planck-Institut für PsychiatrieMünchenGermany
  2. 2.Klinik für Psychiatrie und Psychotherapie, Charité Campus MitteCharité — Universitätsmedizin BerlinBerlinGermany

Bibliographic information